Bemarituzumab with chemotherapy for untreated inoperable HER2-negative advanced gastric or gastro-oesophageal junction cancer [ID6481]

  • Awaiting development
  • GID-TA11607
  • Expected publication date: 

Documents

Documents created during the development process.

Referral

Referral

Topic selection